|
|
| | Raltegravir USP Impurity C Basic information |
| Product Name: | Raltegravir USP Impurity C | | Synonyms: | Raltegravir USP Impurity C;4-Pyrimidinecarboxamide, 2-[1-[[(dimethylamino)methylene]amino]-1-methylethyl]-N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-;Raltegravir Impurity 2（Raltegravir EP Impurity B）;Raltegravir Formididyl Analog;N'-{2-[4-({[(4-fluorophenyl)methyl]amino}(hydroxy)methylidene)-1-methyl-5,6-dioxo-1,4,5,6-tetrahydropyrimidin-2-yl]propan-2-yl}-N,N-dimethylmethanimidamide;(Z)-2-(2-(((Dimethylamino)methylene)amino)propan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide;2-(2-{[(dimethylamino)methylidene]amino}propan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide;Raltegravir potassium EP Impurity B | | CAS: | 1193687-85-2 | | MF: | C19H24FN5O3 | | MW: | 389.42 | | EINECS: | | | Product Categories: | | | Mol File: | 1193687-85-2.mol |  |
| | Raltegravir USP Impurity C Chemical Properties |
| density | 1.245±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 4.500±1.00(predicted) | | form | Solid | | color | White |
| | Raltegravir USP Impurity C Usage And Synthesis |
| Uses | 2-Des(5-methyl-1,3,4-oxadiazole-2-carboxamide) (E)-2-(N,N-Dimethylformimidamide) Raltegravir is an impurity of Raltegravir (R100300), a potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug. |
| | Raltegravir USP Impurity C Preparation Products And Raw materials |
|